Propafenone hydrochloride 225 MG Oral Tablet — RxCUI 861427
RxNorm drug concept · Semantic clinical drug
RxCUI 861427
Semantic clinical drug · SCD
● Current RxNorm concept 19 FDA products
25 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI861427
Official namePropafenone hydrochloride 225 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspropafenone HCl 225 MG Oral Tablet
FDA products mapped19
Package NDCs mapped25
Reported Medicaid activity (SDUD)7,732 prescriptions · 28 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Propafenone: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Think of it as an electrical 'slow-down' for your heart. Your heart has channels that carry electrical signals triggering each beat — propafenone partially blocks those channels so...
- What exactly is propafenone doing for my heart?
- Yes, a few important ones. Grapefruit juice can raise propafenone levels in your blood, so it's best to avoid it. Several medications — including some antidepressants like paroxeti...
- Are there foods or common medications I should avoid while taking this?
🕸️ Concept Web — How Propafenone hydrochloride 225 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Propafenone hydrochloride 225 MG Oral Tablet
RxCUI 861427 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Propafenone
8754IN -
Propafenone hydrochloride
203135PIN
-
Propafenone
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Propafenone Oral Tablet
373637SCDF -
Propafenone hydrochloride Oral Tablet
2648198SCDFP -
Propafenone Oral Product
1162317SCDG -
Propafenone Pill
1162318SCDG -
Propafenone hydrochloride Oral Product
2663268SCDGP -
Propafenone hydrochloride Pill
2662243SCDGP -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Propafenone Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Propafenone hydrochloride 225 MG
861155SCDC
-
Propafenone hydrochloride 225 MG
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Propafenone hydrochloride 225 MG
SCDC · 861155 -
Propafenone Oral Tablet
SCDF · 373637 -
Propafenone hydrochloride Oral Tablet
SCDFP · 2648198 -
Propafenone Oral Product
SCDG · 1162317 -
Propafenone Pill
SCDG · 1162318 -
Propafenone hydrochloride Oral Product
SCDGP · 2663268 -
Propafenone hydrochloride Pill
SCDGP · 2662243
📦 FDA Products & Package NDCs
19 products · 25 package NDCs
25 package NDCs map to RxCUI 861427 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 50090-4227-00 | 60 TABLET, COATED in 1 BOTTLE (50090-4227-0) | Propafenone Hydrochloride | A-S Medication Solutions | 2019-03-27 |
| 51407-0015-01 | 100 TABLET, COATED in 1 BOTTLE (51407-015-01) | Propafenone Hydrochloride | Golden State Medical Supply, Inc. | 2022-09-08 |
| 51407-0016-01 | 100 TABLET, COATED in 1 BOTTLE (51407-016-01) | Propafenone Hydrochloride | Golden State Medical Supply, Inc. | 2017-12-11 |
| 51407-0017-01 | 100 TABLET, COATED in 1 BOTTLE (51407-017-01) | Propafenone Hydrochloride | Golden State Medical Supply, Inc. | 2017-12-11 |
| 59651-0256-01 | 100 TABLET, FILM COATED in 1 BOTTLE (59651-256-01) | PROPAFENONE HYDROCHLORIDE | Aurobindo Pharma Limited | 2019-10-25 |
| 59651-0256-33 | 300 TABLET, FILM COATED in 1 BOTTLE (59651-256-33) | PROPAFENONE HYDROCHLORIDE | Aurobindo Pharma Limited | 2019-10-25 |
| 59651-0257-01 | 100 TABLET, FILM COATED in 1 BOTTLE (59651-257-01) | PROPAFENONE HYDROCHLORIDE | Aurobindo Pharma Limited | 2019-10-25 |
| 59651-0257-33 | 300 TABLET, FILM COATED in 1 BOTTLE (59651-257-33) | PROPAFENONE HYDROCHLORIDE | Aurobindo Pharma Limited | 2019-10-25 |
| 59651-0258-01 | 100 TABLET, FILM COATED in 1 BOTTLE (59651-258-01) | PROPAFENONE HYDROCHLORIDE | Aurobindo Pharma Limited | 2019-10-25 |
| 62559-0230-01 | 100 TABLET, COATED in 1 BOTTLE (62559-230-01) | Propafenone Hydrochloride | ANI Pharmaceuticals, Inc. | 2015-03-31 |
| 62559-0231-01 | 100 TABLET, COATED in 1 BOTTLE (62559-231-01) | Propafenone Hydrochloride | ANI Pharmaceuticals, Inc. | 2015-03-31 |
| 62559-0232-01 | 100 TABLET, COATED in 1 BOTTLE (62559-232-01) | Propafenone Hydrochloride | ANI Pharmaceuticals, Inc. | 2015-03-31 |
| 63629-1988-01 | 100 TABLET, COATED in 1 BOTTLE (63629-1988-1) | Propafenone Hydrochloride | Bryant Ranch Prepack | 2021-02-02 |
| 64380-0163-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64380-163-01) | PROPAFENONE HYDROCHLORIDE | Strides Pharma Science Limited | 2022-08-01 |
| 64380-0164-01 | 300 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64380-164-01) | PROPAFENONE HYDROCHLORIDE | Strides Pharma Science Limited | 2022-08-01 |
| 64380-0164-02 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64380-164-02) | PROPAFENONE HYDROCHLORIDE | Strides Pharma Science Limited | 2022-08-01 |
| 64380-0165-01 | 300 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64380-165-01) | PROPAFENONE HYDROCHLORIDE | Strides Pharma Science Limited | 2022-08-01 |
| 64380-0165-02 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64380-165-02) | PROPAFENONE HYDROCHLORIDE | Strides Pharma Science Limited | 2022-08-01 |
| 64380-0246-01 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64380-246-01) | PROPAFENONE HYDROCHLORIDE | Strides Pharma Science Limited | 2025-05-05 |
| 64380-0268-01 | 300 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64380-268-01) | PROPAFENONE HYDROCHLORIDE | Strides Pharma Science Limited | 2025-05-05 |
| 64380-0268-02 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64380-268-02) | PROPAFENONE HYDROCHLORIDE | Strides Pharma Science Limited | 2025-05-05 |
| 64380-0269-01 | 300 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64380-269-01) | PROPAFENONE HYDROCHLORIDE | Strides Pharma Science Limited | 2025-05-05 |
| 64380-0269-02 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (64380-269-02) | PROPAFENONE HYDROCHLORIDE | Strides Pharma Science Limited | 2025-05-05 |
| 72162-1752-01 | 100 TABLET, COATED in 1 BOTTLE (72162-1752-1) | Propafenone Hydrochloride | Bryant Ranch Prepack | 2024-02-07 |
| 72162-2617-01 | 100 TABLET, FILM COATED in 1 BOTTLE (72162-2617-1) | PROPAFENONE HYDROCHLORIDE | Bryant Ranch Prepack | 2026-04-20 |
Observed labelers:
Strides Pharma Science Limited (10) ·
Aurobindo Pharma Limited (5) ·
ANI Pharmaceuticals, Inc. (3) ·
Bryant Ranch Prepack (3) ·
Golden State Medical Supply, Inc. (3) ·
A-S Medication Solutions (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.